T1	Intervention 1 218	Mitomycin C plus HCFU adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma. (Second report): 5-year survival rate. Cooperative Study Group of Kyushu and Chugoku for HCFU Adjuvant Chemotherapy
T2	Intervention 891 1262	In Group A, the MMC group received bolus intravenous injections of 20 mg MMC on the day of operation and 10 mg the next day, followed by 10 mg every 4 weeks until a total of 100 mg had been administered. In Group B, the MMC + HCFU group received the same treatment in Group A, but with the addition of 600 mg/day of HCFU from the second week, orally for at least one year
